Targeting molecular pathway that causes pulmonary arterial hypertension
Researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
Read Original Article: Targeting molecular pathway that causes pulmonary arterial hypertension »
